v3 Template
S

Somagenetix AG

Biotechnology ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$11.0M
Funding Rounds
1
Last Funding
2024-10-08

About Somagenetix AG

Somagenetix is a biotech company focused on revolutionizing gene therapy for phagocyte disorders. Their mission is to develop innovative, one-time treatments using lentivirus-transduced stem cells to cure genetic disorders, prioritizing specificity, safety, and lifelong effectiveness, with the goal of improving patients' lives worldwide.

Products & Services

SGX-001:Lead therapy for curing Chronic Granulomatous Disease (CGD), a serious immune deficiency. It has completed pre-clinical development with strong safety and efficacy results and is on track for human clinical trials in 2026.
Gene Therapy Platform:A proprietary platform utilizing lentivirus-transduced stem cells to target over 50 known genetic disorders, focusing on cellular specificity and therapeutic effectiveness.

Specialties

Gene Therapy Phagocyte Disorders Immunology Clinical Research Lentiviral Therapy Chronic Granulomatous Disease (CGD)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 11000000
MR: -
FA: CHF 10 million
FAN: 11000000 		D: 2024-10-08
FD: 2024-10-08 		4 investors
Series A Latest
2024-10-08
$11.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Diego Braguglia

Chairman of the Board of Directors

LinkedIn (Pro only)
J

Janine Reichenbach

Founder & Member of the Board of Directors

LinkedIn (Pro only)
E

Eric Lohrer

Member of the Board of Directors

LinkedIn (Pro only)
J

Joshi Venugopal

Member of the Board of Directors

A

Andrin Oswald

CEO

E

Erik Rutjens

Chief Technology Officer

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Somagenetix AG Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro